New research finds that stimulating specific receptors is expected to promote new bone formation, opening up new opportunities for osteoporosis treatment

2026/06/27 15:11

Osteoporosis is a common disease among middle-aged and elderly people. The latest research has found that stimulating specific receptors is expected to promote new bone formation, bringing new opportunities for treatment. Situational photo, the characters in the picture have nothing to do with this article. (Picture taken from Shutterstock)

[Compiled by Chen Chengliang/Comprehensive Report] There is hope for a new breakthrough in the treatment of osteoporosis. A German research team has discovered a new mechanism that can directly stimulate osteoblasts. After activation with experimental drugs, it not only improves bone density and bone strength in mice, but also improves bone loss. It is expected to provide new treatment directions for osteoporosis patients in the future.

According to "Science Alert", this research was led by a team from Leipzig University in Germany. The study focused on a receptor called GPR133. Researchers found that when the receptor is activated, it can stimulate the operation of osteoblasts and promote new bone formation. Relevant results have been published in the international journal "Signal Transduction and Targeted Therapy".

Human bones are not static, but are constantly undergoing bone decomposition and new bone formation. When you are young, the rate of bone building is usually faster than bone loss; however, as you age, your bone building ability gradually decreases and bone mass decreases, which may lead to osteoporosis.

Many existing drugs reduce bone loss, new research directly stimulates osteoblasts

The research team used an experimental compound called AP503 to activate the GPR133 receptor and found that the treated mice increased bone mass, improved trabecular bone structure, and increased bone strength simultaneously. Improvements were also observed in animal models simulating postmenopausal osteoporosis.

Researchers pointed out that the main function of most current osteoporosis drugs is to slow down bone loss, and the treatments that can actually promote new bone formation are still quite limited. The importance of this discovery lies in finding a new pathway that can directly stimulate osteoblasts, which may help rebuild lost bone mass in the future.

The research team emphasized that the current results are still in the animal experiment stage and have not yet entered human clinical trials. Therefore, more safety and efficacy verifications are still needed before actual medical application.

Osteoporosis affects hundreds of millions of people around the world, with postmenopausal women and the elderly at greatest risk. The research team stated that if subsequent human trials confirm the same effect, this new mechanism is expected to become a new strategy for treating osteoporosis and reducing the risk of fractures in the future.